Anti-chondroitin sulfate proteoglycan 4-specific antibodies modify the effects of vemurafenib on melanoma cells differentially in normoxia and hypoxia
Daniela Pucciarelli(Medical University of Vienna), Christine Häfner(Karl Landsteiner University of Health Sciences)
Cited by 16
Related Papers
<scp>EAACI</scp>Molecular Allergology User's Guide 2.0
|Pediatric Allergy and Immunology|2023|259